Since joining the group in 2019, Xing has supported projects related to clinical trials, Part D formulary, and healthcare utilization.
He graduated in 2019 from the University of Minnesota – Twin Cities with a Master of Science in Biostatistics and a BS in mathematics from the University of Georgia.